LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization

, ,

On Apr. 21, 2020, LabCorpᆴ announced it has received an Emergency Use Authorization (EUA) from the FDA. The EUA permits nasal swab specimens to be collected at home using the Pixel by LabCorpル COVID-19 test home collection kit if recommended by a healthcare provider after completing a COVID-19 questionnaire.

Tags:


Source: LabCorp
Credit: